Your browser doesn't support javascript.
loading
Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.
Price, H C; Coleman, R L; Stevens, R J; Holman, R R.
Affiliation
  • Price HC; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, UK. Hermione.Price@dtu.ox.ac.uk
Diabetologia ; 52(3): 394-7, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19048226
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Diabetic Angiopathies Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetologia Year: 2009 Document type: Article Affiliation country: Reino Unido Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Diabetic Angiopathies Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetologia Year: 2009 Document type: Article Affiliation country: Reino Unido Country of publication: Alemania